LONGINO & CARDENAL - SPA (LON.MI) Fundamental Analysis & Valuation

BIT:LON • IT0005337073

Current stock price

0.835 EUR
+0.02 (+2.45%)
Last:

This LON.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. LON.MI Profitability Analysis

1.1 Basic Checks

  • In the past year LON has reported negative net income.
  • LON had a positive operating cash flow in the past year.
  • LON had negative earnings in each of the past 5 years.
  • LON had negative operating cash flow in 4 of the past 5 years.
LON.MI Yearly Net Income VS EBIT VS OCF VS FCFLON.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

  • The Return On Assets of LON (-1.90%) is worse than 69.35% of its industry peers.
  • LON has a Return On Equity (-8.57%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 0.55%, LON is not doing good in the industry: 69.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.9%
ROE -8.57%
ROIC 0.55%
ROA(3y)-3.79%
ROA(5y)-5.08%
ROE(3y)-15.27%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
LON.MI Yearly ROA, ROE, ROICLON.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

  • LON has a worse Operating Margin (0.16%) than 72.58% of its industry peers.
  • LON's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LON (16.66%) is worse than 69.35% of its industry peers.
  • In the last couple of years the Gross Margin of LON has remained more or less at the same level.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM 16.66%
OM growth 3YN/A
OM growth 5Y-47.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.93%
GM growth 5Y1.37%
LON.MI Yearly Profit, Operating, Gross MarginsLON.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. LON.MI Health Analysis

2.1 Basic Checks

  • LON has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for LON remains at a similar level compared to 1 year ago.
  • LON has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LON has an improved debt to assets ratio.
LON.MI Yearly Shares OutstandingLON.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
LON.MI Yearly Total Debt VS Total AssetsLON.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • LON has an Altman-Z score of 2.30. This is not the best score and indicates that LON is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LON has a better Altman-Z score (2.30) than 61.29% of its industry peers.
  • The Debt to FCF ratio of LON is 10.09, which is on the high side as it means it would take LON, 10.09 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.09, LON is doing worse than 61.29% of the companies in the same industry.
  • LON has a Debt/Equity ratio of 0.75. This is a neutral value indicating LON is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.75, LON is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 10.09
Altman-Z 2.3
ROIC/WACC0.09
WACC6.16%
LON.MI Yearly LT Debt VS Equity VS FCFLON.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that LON should not have too much problems paying its short term obligations.
  • The Current ratio of LON (1.26) is better than 80.65% of its industry peers.
  • LON has a Quick Ratio of 1.02. This is a normal value and indicates that LON is financially healthy and should not expect problems in meeting its short term obligations.
  • LON's Quick ratio of 1.02 is fine compared to the rest of the industry. LON outperforms 66.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.02
LON.MI Yearly Current Assets VS Current LiabilitesLON.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. LON.MI Growth Analysis

3.1 Past

  • LON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -913.30%.
  • The Revenue has decreased by -0.77% in the past year.
  • The Revenue has been growing slightly by 1.74% on average over the past years.
EPS 1Y (TTM)-913.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.31%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y11.77%
Revenue growth 5Y1.74%
Sales Q2Q%-4.4%

3.2 Future

  • LON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.61% yearly.
  • LON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.30% yearly.
EPS Next Y114.29%
EPS Next 2Y117.12%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue Next Year0.94%
Revenue Next 2Y3.62%
Revenue Next 3Y4.94%
Revenue Next 5Y3.3%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LON.MI Yearly Revenue VS EstimatesLON.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
LON.MI Yearly EPS VS EstimatesLON.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

6

4. LON.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LON. In the last year negative earnings were reported.
  • LON is valuated reasonably with a Price/Forward Earnings ratio of 8.70.
  • LON's Price/Forward Earnings ratio is rather cheap when compared to the industry. LON is cheaper than 96.77% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of LON to the average of the S&P500 Index (22.84), we can say LON is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.7
LON.MI Price Earnings VS Forward Price EarningsLON.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • LON's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, LON is valued cheaper than 83.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.62
EV/EBITDA 17.59
LON.MI Per share dataLON.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • LON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LON's earnings are expected to grow with 72.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.12%
EPS Next 3Y72.61%

0

5. LON.MI Dividend Analysis

5.1 Amount

  • LON does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LON.MI Fundamentals: All Metrics, Ratios and Statistics

LONGINO & CARDENAL - SPA

BIT:LON (2/9/2026, 7:00:00 PM)

0.835

+0.02 (+2.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners8.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.22M
Revenue(TTM)36.76M
Net Income(TTM)-367.00K
Analysts80
Price Target2.53 (202.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-23.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-94.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.7
P/S 0.14
P/FCF 6.62
P/OCF 5.14
P/B 1.22
P/tB 1.52
EV/EBITDA 17.59
EPS(TTM)-0.24
EYN/A
EPS(NY)0.1
Fwd EY11.49%
FCF(TTM)0.13
FCFY15.11%
OCF(TTM)0.16
OCFY19.47%
SpS6.01
BVpS0.69
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.9%
ROE -8.57%
ROCE 0.73%
ROIC 0.55%
ROICexc 0.72%
ROICexgc 0.83%
OM 0.16%
PM (TTM) N/A
GM 16.66%
FCFM 2.1%
ROA(3y)-3.79%
ROA(5y)-5.08%
ROE(3y)-15.27%
ROE(5y)-17.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-47.34%
ROICexc growth 3YN/A
ROICexc growth 5Y-46.53%
OM growth 3YN/A
OM growth 5Y-47.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.93%
GM growth 5Y1.37%
F-Score6
Asset Turnover1.94
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 10.09
Debt/EBITDA 4.99
Cap/Depr 39.28%
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion 158.88%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.02
Altman-Z 2.3
F-Score6
WACC6.16%
ROIC/WACC0.09
Cap/Depr(3y)89.53%
Cap/Depr(5y)161.15%
Cap/Sales(3y)1.76%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-913.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-508.31%
EPS Next Y114.29%
EPS Next 2Y117.12%
EPS Next 3Y72.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y11.77%
Revenue growth 5Y1.74%
Sales Q2Q%-4.4%
Revenue Next Year0.94%
Revenue Next 2Y3.62%
Revenue Next 3Y4.94%
Revenue Next 5Y3.3%
EBIT growth 1Y-48.26%
EBIT growth 3YN/A
EBIT growth 5Y-46.44%
EBIT Next Year271.43%
EBIT Next 3Y78.78%
EBIT Next 5Y58.5%
FCF growth 1Y155.56%
FCF growth 3YN/A
FCF growth 5Y36.57%
OCF growth 1Y359.83%
OCF growth 3YN/A
OCF growth 5Y1.09%

LONGINO & CARDENAL - SPA / LON.MI Fundamental Analysis FAQ

What is the fundamental rating for LON stock?

ChartMill assigns a fundamental rating of 3 / 10 to LON.MI.


What is the valuation status for LON stock?

ChartMill assigns a valuation rating of 6 / 10 to LONGINO & CARDENAL - SPA (LON.MI). This can be considered as Fairly Valued.


How profitable is LONGINO & CARDENAL - SPA (LON.MI) stock?

LONGINO & CARDENAL - SPA (LON.MI) has a profitability rating of 1 / 10.


What is the expected EPS growth for LONGINO & CARDENAL - SPA (LON.MI) stock?

The Earnings per Share (EPS) of LONGINO & CARDENAL - SPA (LON.MI) is expected to grow by 114.29% in the next year.


How sustainable is the dividend of LONGINO & CARDENAL - SPA (LON.MI) stock?

The dividend rating of LONGINO & CARDENAL - SPA (LON.MI) is 0 / 10 and the dividend payout ratio is 0%.